查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2134655

基於雲端的藥物發現平台市場：全球市場預測（2026-2032年）

Cloud Based Drug Discovery Platform Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，基於雲端的藥物發現平台市場將成長至 39.8 億美元，複合年成長率為 13.40%。

主要市場統計數據
基準年 2025 16.5億美元
預計年份：2026年 18.6億美元
預測年份 2032 39.8億美元
複合年成長率 (%) 13.40%

基於雲端的藥物發現平台：執行摘要

基於雲端的藥物發現平台為研發團隊提供遠端存取的運算、資料管理、協作和工作流程功能。隨著各機構尋求連接分散的科研團隊、管理複雜的資料集、支持可復現的工作流程以及將計算方法與實驗室活動相結合，這些平台的重要性日益凸顯。在考慮實施時，應將資料管治、互通性、檢驗、網路安全、監管要求以及運行複雜藥物發現環境所需的技術技能等因素納入考慮。

分散式研究和整合工作流程正在改變藥物發現的方式。

藥物研發正從孤立的、本地部署的工具轉向整合分子建模、篩檢、生物資訊學、實驗室文件和協作的互聯環境。基於雲端的交付方式可以改善對專用運算資源的訪問，並為地理位置分散的團隊提供支援。共用資料環境還可以減少重複工作，提高可追溯性。同時，各組織必須應對轉型過程中的複雜性，例如資料標準不一致、舊有系統、智慧財產權保護，以及在影響受監管決策之前檢驗計算結果的必要性。

人工智慧在加速自動化的同時，也提高了檢驗的標準。

人工智慧正被應用於標靶辨識、分子設計、虛擬篩檢、生物標記分析、影像解讀和實驗優先排序。雖然雲端基礎設施能夠支援這些應用所需的儲存、處理和協作開發，但模型效能取決於資料品質、代表性的訓練集、透明的文件記錄和適當的監控。產業領導者必須將人工智慧產生的結果視為決策支援的輸入，建立人工審核和審計追蹤機制，評估偏差和可重複性，並使模型管治符合科學和監管要求。

區域性見解：全球不同研究生態系的實施優先順序有所不同。

北美充分利用其強大的製藥、生物技術、學術和技術實力，重點關注可擴展計算、轉化研究、網路安全以及與實驗室系統的整合。歐洲尤其重視隱私、資料管治、互通性和跨國合作。亞太地區研究能力不斷提升，但數位化成熟度參差不齊，因此需要彈性應用和人才培養。拉丁美洲致力於改善先進工具的取得途徑、加強研究網路並解決基礎設施瓶頸問題。中東正在加速對知識密集型產業和數位研究能力的投資，而非洲的優先事項包括經濟實惠的獲取途徑、本地專業知識、衛生研究能力和可靠的網路連接。

集團洞察：政策一致性和協調性將決定平台部署的準備。

東南亞國協的基礎設施、監管成熟度和研究專業化程度各不相同，因此互通性和區域技能發展至關重要。金磚國家擁有相當可觀的科技和產業實力，但需要採取能夠應對不同數據、政策和基礎設施環境的方法。歐盟優先考慮隱私、跨境資料利用、研究合作和負責任的人工智慧。七國集團成員國普遍優先考慮進階分析、具有韌性的數位基礎設施和健全的管治。海灣合作理事會成員國正在建立技術驅動型研究生態系統，並可能優先考慮國家能力建設和安全的數據環境。北約成員國尤其重視網路安全、韌性、可信賴的合作以及敏感科學資訊的保護。

國別分析：每個國家的優勢都必須與管治和技能連結。

美國和加拿大擁有成熟的科研生態系統，同時對擴充性的分析、安全的協作和工作流程整合有著強烈的需求。英國、德國、法國、義大利和西班牙優先考慮科研夥伴關係、資料管治以及遵守歐洲相關規定。澳洲支持跨機構進行數位化驅動的生物醫學研究。中國、日本、韓國和印度擁有強大的科學研究實力，並具備各自獨特的監管、基礎設施和資料管治環境。巴西和墨西哥正在拓展其數位化科學研究能力，同時也努力滿足基礎設施、資金和人才方面的需求。俄羅斯的數位化應用環境受到其國內技術因素、科學研究連續性和專用運算資源取得情況的影響。在這些國家，檢驗的工作流程、可互通的資料、網路安全以及持續的使用者培訓對於成功應用至關重要。

領導者的行動重點：建立管治並建構可互通的發現基礎。

領導者應從明確定義的科學應用案例和可衡量的工作流程目標入手，而非盲目地採用新技術。在整合敏感研究資料之前，必須建立資料分類、身分和存取控制、加密、可審計性、備份和事件回應等流程。選擇平台時，應優先考慮開放介面、資料來源、可複現性、與實驗室和分析系統的整合以及跨環境的可攜性。組織應透過受控的試點運作、獨立檢驗、完善的模型管治以及人工監督來實施人工智慧。最後，應在運算生物學、資料工程、雲端營運、網路安全和變更管理方面進行投資，以確保平台部署能夠產生永續的科學價值。

調查方法：基於證據的平台實施條件評估。

本執行摘要對目前基於雲端的藥物發現平台的現狀進行了結構化的定性評估。分析涵蓋了技術能力、藥物發現工作流程、人工智慧應用、資料管治、互通性、網路安全、法規環境、組織準備以及區域差異。透過整合來自特定區域、國家群體以及跨國界的洞察，我們辨識出反覆出現的採用促進因素、實施障礙和策略重點。這種方法避免了未經證實的數位論斷，而是著重於影響平台採用和有效使用的檢驗的結構性因素。

結論：負責任地採用雲端運算可以加強藥物研發領域的合作。

基於雲端的藥物發現平台幫助研究機構在日益分散的工作流程中連接團隊、運算資源和科學數據。其有效性更取決於可信任的資料管理實務、可互通的架構、檢驗的分析方法、網路安全以及熟練的用戶，而非基礎設施本身。那些能夠將嚴謹的管治、精心挑選的人工智慧應用和可衡量的科學目標相結合的機構，將更有利於提高協作品質、可重複性和決策水平，同時有效管理營運和監管風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 基於雲端的藥物發現平台市場：依技術類型分類

  • 人工智慧
    • 深度學習
    • 神經網路
    • 預測分析
  • 生物資訊學
    • 基因組學
    • 代謝體學
    • 蛋白質體學
  • 高效能運算
    • 分散式運算
    • GPU 運算
  • 機器學習
    • 強化學習
    • 監督式學習
    • 無監督學習
  • 分子建模
    • 對接
    • QSAR
    • 模擬

第8章：基於雲端的藥物發現平台市場：按服務模式分類

  • Infrastructure as a Service
    • 計算服務
    • 儲存服務
  • Platform as a Service
    • 容器平台
    • 微服務
  • Software as a Service
    • 行動平台
    • 網路入口網站

第9章 基於雲端的藥物發現平台市場：按治療領域分類

  • 心血管系統
    • 心臟衰竭
    • 高血壓
  • 免疫學
    • 自體免疫疾病
    • 免疫力缺乏
  • 感染疾病
    • 細菌感染疾病
    • 黴菌感染疾病
    • 病毒感染疾病
  • 神經病學
    • 阿茲海默症
    • 帕金森氏症
  • 腫瘤學
    • 血癌
    • 固體癌

第10章：基於雲端的藥物發現平台市場：依部署模式分類

  • 混合雲端
    • 整合雲
    • 多重雲端
  • 私有雲端
    • 託管私有雲端
    • 現場
  • 公共雲端
    • AWS
    • Azure
    • Google Cloud

第11章 基於雲端的藥物發現平台市場：按應用領域分類

  • ADMET預測
    • 吸收
    • 分配
    • 排泄
    • 代謝
    • 毒性
  • 臨床試驗設計
    • 患者分層
    • 測試模擬
  • 藥物再利用
    • 計算篩檢
    • 相似性分析
  • 發現鉛
    • 命中識別
    • 命中率最佳化
  • 目標識別
    • 基因檢驗
    • 蛋白質鑑定

第12章 基於雲端的藥物發現平台市場：以最終用戶分類

  • 學術研究機構
    • 研究機構
    • 大學
  • 生技公司
    • 一家歷史悠久的生物技術公司
    • 生技新創企業
  • 受託研究機構
    • 全方位服務
    • 利基服務
  • 製藥公司
    • 學名藥
    • 大型製藥企業
    • 中型製藥公司

第13章 基於雲端的藥物發現平台市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 基於雲端的藥物發現平台市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 基於雲端的藥物發現平台市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Accenture PLC
  • Acelot, Inc.
  • Amazon Web Services, Inc.
  • Atomwise, Inc.
  • Benchling, Inc.
  • BioSymetrics Inc.
  • BioXcel Corporation
  • Certara, LP
  • Cloud Pharmaceuticals, Inc.
  • Collaborative Drug Discovery, Inc.
  • Cyclica Inc.
  • Dassault Systemes SE
  • Deep Genomics, Inc.
  • Google LLC
  • IBM Corporation
  • Insilico Medicine, Inc.
  • Microsoft Corporation
  • Numerate, Inc.
  • Oracle Corporation
  • PerkinElmer, Inc.
  • Recursion Pharmaceuticals, Inc.
  • SAS Institute Inc.
  • Schrodinger, Inc.
  • Tata Consultancy Services Limited
  • WuXi AppTec（Shanghai）Co., Ltd.

第18章 主要專家

Product Code: MRR-F774F6337019

The Cloud Based Drug Discovery Platform Market is projected to grow by USD 3.98 billion at a CAGR of 13.40% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.65 billion
Estimated Year [2026] USD 1.86 billion
Forecast Year [2032] USD 3.98 billion
CAGR (%) 13.40%

Cloud-Based Drug Discovery Platforms: Executive Summary

Cloud-based drug discovery platforms provide remotely accessible computational, data-management, collaboration, and workflow capabilities for research and development teams. Their relevance is increasing as organizations seek to connect distributed scientific groups, manage complex datasets, support reproducible workflows, and integrate computational methods with laboratory activity. Adoption considerations include data governance, interoperability, validation, cybersecurity, regulatory expectations, and the technical skills required to operate advanced discovery environments.

Distributed Research and Integrated Workflows Are Reshaping Discovery

Drug discovery is shifting from isolated, locally installed tools toward connected environments that can combine molecular modeling, screening, bioinformatics, laboratory records, and collaboration. Cloud delivery can improve access to specialized computing resources and support geographically distributed teams, while shared data environments may reduce duplication and improve traceability. At the same time, organizations must manage migration complexity, inconsistent data standards, legacy systems, intellectual-property protection, and the need to validate computational outputs before they influence regulated decisions.

Artificial Intelligence Is Increasing Automation While Raising Validation Requirements

Artificial intelligence is being applied to target identification, molecular design, virtual screening, biomarker analysis, image interpretation, and prioritization of experiments. Cloud infrastructure can support the storage, processing, and collaborative development required by these applications, but model performance depends on data quality, representative training sets, transparent documentation, and appropriate monitoring. Industry leaders should treat AI-generated results as decision-support inputs, establish human review and audit trails, assess bias and reproducibility, and align model governance with scientific and regulatory requirements.

Regional Insights: Adoption Priorities Differ Across Global Research Ecosystems

North America benefits from strong pharmaceutical, biotechnology, academic, and technology capabilities, with emphasis on scalable computation, translational research, cybersecurity, and integration with laboratory systems. Europe places particular importance on privacy, data governance, interoperability, and cross-border collaboration. Asia-Pacific combines expanding research capacity with varied digital maturity, creating demand for flexible deployment and workforce development. Latin America is focused on improving access to advanced tools, strengthening research networks, and addressing infrastructure constraints. The Middle East is investing in knowledge-intensive sectors and digital research capabilities, while Africa's priorities include affordable access, local expertise, health-research capacity, and reliable connectivity.

Group Insights: Policy Alignment and Collaboration Shape Platform Readiness

ASEAN economies show diverse levels of infrastructure, regulatory maturity, and research specialization, making interoperability and regional skills development important. BRICS members bring substantial scientific and industrial capabilities but require approaches that accommodate varied data, policy, and infrastructure environments. The European Union emphasizes privacy, cross-border data use, research collaboration, and responsible AI. G7 members generally prioritize advanced analytics, resilient digital infrastructure, and rigorous governance. GCC countries are developing technology-enabled research ecosystems and may emphasize national capability building and secure data environments. NATO members place added importance on cybersecurity, resilience, trusted collaboration, and protection of sensitive scientific information.

Country Insights: National Strengths Must Be Matched With Governance and Skills

The United States and Canada combine mature research ecosystems with strong demand for scalable analytics, secure collaboration, and workflow integration. The United Kingdom, Germany, France, Italy, and Spain emphasize research partnerships, data governance, and alignment with European requirements. Australia supports digitally enabled biomedical research across dispersed institutions. China, Japan, South Korea, and India combine substantial scientific capabilities with distinct regulatory, infrastructure, and data-governance environments. Brazil and Mexico are expanding digital research capacity while addressing infrastructure, funding, and specialist-workforce needs. Russia's adoption environment is shaped by domestic technology considerations, research continuity, and access to specialized computational resources. Across these countries, successful implementation depends on validated workflows, interoperable data, cybersecurity, and sustained user training.

Action Priorities for Leaders: Build a Governed, Interoperable Discovery Foundation

Leaders should begin with clearly defined scientific use cases and measurable workflow objectives rather than broad technology deployment. They should establish data classification, identity and access controls, encryption, auditability, backup, and incident-response procedures before consolidating sensitive research data. Platform selection should prioritize open interfaces, provenance, reproducibility, integration with laboratory and analytics systems, and portability across environments. Organizations should introduce AI through controlled pilots, independent validation, documented model governance, and human oversight. Finally, they should invest in computational biology, data engineering, cloud operations, cybersecurity, and change management so that platform adoption produces durable scientific value.

Research Methodology: Evidence-Led Assessment of Platform Adoption Conditions

This executive summary uses a structured qualitative assessment of the cloud-based drug discovery platform landscape. The analysis considers technology capabilities, discovery workflows, AI applications, data governance, interoperability, cybersecurity, regulatory context, organizational readiness, and regional variation. Insights are synthesized across the specified regions, country groupings, and countries to identify recurring adoption drivers, implementation barriers, and strategic priorities. The approach avoids unsupported numerical claims and focuses on verifiable structural factors that influence platform deployment and effective use.

Conclusion: Responsible Cloud Adoption Can Strengthen Discovery Collaboration

Cloud-based drug discovery platforms can help research organizations connect teams, computational resources, and scientific data across increasingly distributed workflows. Their effectiveness will depend less on infrastructure alone than on trusted data practices, interoperable architecture, validated analytics, cybersecurity, and skilled users. Organizations that combine disciplined governance with carefully selected AI applications and measurable scientific objectives will be better positioned to improve collaboration, reproducibility, and decision quality while managing operational and regulatory risk.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cloud Based Drug Discovery Platform Market, by Technology Type

  • 7.1. Introduction
  • 7.2. Artificial Intelligence
    • 7.2.1. Deep Learning
    • 7.2.2. Neural Networks
    • 7.2.3. Predictive Analytics
  • 7.3. Bioinformatics
    • 7.3.1. Genomics
    • 7.3.2. Metabolomics
    • 7.3.3. Proteomics
  • 7.4. High Performance Computing
    • 7.4.1. Distributed Computing
    • 7.4.2. GPU Computing
  • 7.5. Machine Learning
    • 7.5.1. Reinforcement Learning
    • 7.5.2. Supervised Learning
    • 7.5.3. Unsupervised Learning
  • 7.6. Molecular Modeling
    • 7.6.1. Docking
    • 7.6.2. QSAR
    • 7.6.3. Simulation

8. Cloud Based Drug Discovery Platform Market, by Service Model

  • 8.1. Introduction
  • 8.2. Infrastructure as a Service
    • 8.2.1. Compute Services
    • 8.2.2. Storage Services
  • 8.3. Platform as a Service
    • 8.3.1. Container Platform
    • 8.3.2. Microservices
  • 8.4. Software as a Service
    • 8.4.1. Mobile Platform
    • 8.4.2. Web Portal

9. Cloud Based Drug Discovery Platform Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular
    • 9.2.1. Heart Failure
    • 9.2.2. Hypertension
  • 9.3. Immunology
    • 9.3.1. Autoimmune Disorders
    • 9.3.2. Immunodeficiency
  • 9.4. Infectious Diseases
    • 9.4.1. Bacterial Infection
    • 9.4.2. Fungal Infection
    • 9.4.3. Viral Infection
  • 9.5. Neurology
    • 9.5.1. Alzheimer Disease
    • 9.5.2. Parkinson Disease
  • 9.6. Oncology
    • 9.6.1. Hematologic Cancers
    • 9.6.2. Solid Tumors

10. Cloud Based Drug Discovery Platform Market, by Deployment Model

  • 10.1. Introduction
  • 10.2. Hybrid Cloud
    • 10.2.1. Integrated Cloud
    • 10.2.2. Multi Cloud
  • 10.3. Private Cloud
    • 10.3.1. Hosted Private Cloud
    • 10.3.2. On Premise
  • 10.4. Public Cloud
    • 10.4.1. AWS
    • 10.4.2. Azure
    • 10.4.3. Google Cloud

11. Cloud Based Drug Discovery Platform Market, by Application

  • 11.1. Introduction
  • 11.2. ADMET Prediction
    • 11.2.1. Absorption
    • 11.2.2. Distribution
    • 11.2.3. Excretion
    • 11.2.4. Metabolism
    • 11.2.5. Toxicity
  • 11.3. Clinical Trial Design
    • 11.3.1. Patient Stratification
    • 11.3.2. Trial Simulation
  • 11.4. Drug Repositioning
    • 11.4.1. Computational Screening
    • 11.4.2. Similarity Analysis
  • 11.5. Lead Discovery
    • 11.5.1. Hit Identification
    • 11.5.2. Hit Optimization
  • 11.6. Target Identification
    • 11.6.1. Gene Validation
    • 11.6.2. Protein Identification

12. Cloud Based Drug Discovery Platform Market, by End User

  • 12.1. Introduction
  • 12.2. Academic Research Institutes
    • 12.2.1. Research Institutes
    • 12.2.2. Universities
  • 12.3. Biotechnology Companies
    • 12.3.1. Established Biotech
    • 12.3.2. Startup Biotech
  • 12.4. Contract Research Organizations
    • 12.4.1. Full Service
    • 12.4.2. Niche Service
  • 12.5. Pharmaceutical Companies
    • 12.5.1. Generics
    • 12.5.2. Large Pharma
    • 12.5.3. Mid Size Pharma

13. Cloud Based Drug Discovery Platform Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Cloud Based Drug Discovery Platform Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Cloud Based Drug Discovery Platform Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Accenture PLC
  • 17.2. Acelot, Inc.
  • 17.3. Amazon Web Services, Inc.
  • 17.4. Atomwise, Inc.
  • 17.5. Benchling, Inc.
  • 17.6. BioSymetrics Inc.
  • 17.7. BioXcel Corporation
  • 17.8. Certara, L.P.
  • 17.9. Cloud Pharmaceuticals, Inc.
  • 17.10. Collaborative Drug Discovery, Inc.
  • 17.11. Cyclica Inc.
  • 17.12. Dassault Systemes SE
  • 17.13. Deep Genomics, Inc.
  • 17.14. Google LLC
  • 17.15. IBM Corporation
  • 17.16. Insilico Medicine, Inc.
  • 17.17. Microsoft Corporation
  • 17.18. Numerate, Inc.
  • 17.19. Oracle Corporation
  • 17.20. PerkinElmer, Inc.
  • 17.21. Recursion Pharmaceuticals, Inc.
  • 17.22. SAS Institute Inc.
  • 17.23. Schrodinger, Inc.
  • 17.24. Tata Consultancy Services Limited
  • 17.25. WuXi AppTec (Shanghai) Co., Ltd.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Cloud Based Drug Discovery Platform Market, Years Considered for the Study
  • FIGURE 2. Global Cloud Based Drug Discovery Platform Market, Research Design
  • FIGURE 3. Global Cloud Based Drug Discovery Platform Market, Research Framework
  • FIGURE 4. Global Cloud Based Drug Discovery Platform Market, Data Triangulation
  • FIGURE 5. Global Cloud Based Drug Discovery Platform Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Cloud Based Drug Discovery Platform Market Size, by Technology Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Cloud Based Drug Discovery Platform Market Size, by Technology Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Cloud Based Drug Discovery Platform Market Size, by Service Model, 2025 vs 2032 (%)
  • FIGURE 9. Global Cloud Based Drug Discovery Platform Market Size, by Service Model, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Cloud Based Drug Discovery Platform Market Size, by Therapeutic Area, 2025 vs 2032 (%)
  • FIGURE 11. Global Cloud Based Drug Discovery Platform Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Cloud Based Drug Discovery Platform Market Size, by Deployment Model, 2025 vs 2032 (%)
  • FIGURE 13. Global Cloud Based Drug Discovery Platform Market Size, by Deployment Model, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Cloud Based Drug Discovery Platform Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 15. Global Cloud Based Drug Discovery Platform Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Cloud Based Drug Discovery Platform Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 17. Global Cloud Based Drug Discovery Platform Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Cloud Based Drug Discovery Platform Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Cloud Based Drug Discovery Platform Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Cloud Based Drug Discovery Platform Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Cloud Based Drug Discovery Platform Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Cloud Based Drug Discovery Platform Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Cloud Based Drug Discovery Platform Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Cloud Based Drug Discovery Platform Market Segmentation & Coverage
  • TABLE 2. Global Cloud Based Drug Discovery Platform Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Cloud Based Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
  • TABLE 4. Global Artificial Intelligence Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Artificial Intelligence Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Artificial Intelligence Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Deep Learning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Deep Learning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Deep Learning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Neural Networks Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Neural Networks Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Neural Networks Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Predictive Analytics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Predictive Analytics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Predictive Analytics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Bioinformatics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Bioinformatics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Bioinformatics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Genomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Genomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Genomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Metabolomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Metabolomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Metabolomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Proteomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Proteomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Proteomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global High Performance Computing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global High Performance Computing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global High Performance Computing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Distributed Computing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Distributed Computing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Distributed Computing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global GPU Computing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global GPU Computing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global GPU Computing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Machine Learning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Machine Learning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Machine Learning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Reinforcement Learning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Reinforcement Learning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Reinforcement Learning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Supervised Learning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Supervised Learning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Supervised Learning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Unsupervised Learning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Unsupervised Learning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Unsupervised Learning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Molecular Modeling Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Molecular Modeling Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Molecular Modeling Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Docking Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Docking Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Docking Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global QSAR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global QSAR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global QSAR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Simulation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Simulation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Simulation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Cloud Based Drug Discovery Platform Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 62. Global Infrastructure as a Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Infrastructure as a Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Infrastructure as a Service Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Compute Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Compute Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Compute Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Storage Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Storage Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Storage Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Platform as a Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Platform as a Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Platform as a Service Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Container Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Container Platform Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Container Platform Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Microservices Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Microservices Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Microservices Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Software as a Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Software as a Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Software as a Service Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Mobile Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Mobile Platform Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Mobile Platform Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Web Portal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Web Portal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Web Portal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Cloud Based Drug Discovery Platform Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 90. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 92. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 93. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 96. Global Hypertension Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 97. Global Hypertension Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 98. Global Hypertension Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 99. Global Immunology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Global Immunology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. Global Immunology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 102. Global Autoimmune Disorders Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Global Autoimmune Disorders Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 104. Global Autoimmune Disorders Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 105. Global Immunodeficiency Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Global Immunodeficiency Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. Global Immunodeficiency Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 108. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 111. Global Bacterial Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Global Bacterial Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. Global Bacterial Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 114. Global Fungal Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 115. Global Fungal Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 116. Global Fungal Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 117. Global Viral Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 118. Global Viral Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. Global Viral Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 120. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 121. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 122. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 123. Global Alzheimer Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 124. Global Alzheimer Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 125. Global Alzheimer Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 126. Global Parkinson Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 127. Global Parkinson Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 128. Global Parkinson Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 129. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 130. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 131. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 132. Global Hematologic Cancers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 133. Global Hematologic Cancers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 134. Global Hematologic Cancers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 135. Global Solid Tumors Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 136. Global Solid Tumors Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 137. Global Solid Tumors Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 138. Global Cloud Based Drug Discovery Platform Market Size, by Deployment Model, 2017-2032 (USD Million)
  • TABLE 139. Global Hybrid Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 140. Global Hybrid Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 141. Global Hybrid Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 142. Global Integrated Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 143. Global Integrated Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 144. Global Integrated Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 145. Global Multi Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 146. Global Multi Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 147. Global Multi Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 148. Global Private Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 149. Global Private Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 150. Global Private Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 151. Global Hosted Private Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 152. Global Hosted Private Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 153. Global Hosted Private Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 154. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 155. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 156. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 157. Global Public Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 158. Global Public Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 159. Global Public Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 160. Global AWS Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 161. Global AWS Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 162. Global AWS Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 163. Global Azure Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 164. Global Azure Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 165. Global Azure Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 166. Global Google Cloud Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 167. Global Google Cloud Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 168. Global Google Cloud Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 169. Global Cloud Based Drug Discovery Platform Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 170. Global ADMET Prediction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 171. Global ADMET Prediction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 172. Global ADMET Prediction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 173. Global Absorption Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 174. Global Absorption Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 175. Global Absorption Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 176. Global Distribution Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 177. Global Distribution Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 178. Global Distribution Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 179. Global Excretion Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 180. Global Excretion Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 181. Global Excretion Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 182. Global Metabolism Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 183. Global Metabolism Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 184. Global Metabolism Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 185. Global Toxicity Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 186. Global Toxicity Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 187. Global Toxicity Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 188. Global Clinical Trial Design Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 189. Global Clinical Trial Design Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 190. Global Clinical Trial Design Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 191. Global Patient Stratification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 192. Global Patient Stratification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 193. Global Patient Stratification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 194. Global Trial Simulation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 195. Global Trial Simulation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 196. Global Trial Simulation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 197. Global Drug Repositioning Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 198. Global Drug Repositioning Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 199. Global Drug Repositioning Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 200. Global Computational Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 201. Global Computational Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 202. Global Computational Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 203. Global Similarity Analysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 204. Global Similarity Analysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 205. Global Similarity Analysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 206. Global Lead Discovery Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 207. Global Lead Discovery Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 208. Global Lead Discovery Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 209. Global Hit Identification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 210. Global Hit Identification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 211. Global Hit Identification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 212. Global Hit Optimization Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 213. Global Hit Optimization Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 214. Global Hit Optimization Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 215. Global Target Identification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 216. Global Target Identification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 217. Global Target Identification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 218. Global Gene Validation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 219. Global Gene Validation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 220. Global Gene Validation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 221. Global Protein Identification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 222. Global Protein Identification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 223. Global Protein Identification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 224. Global Cloud Based Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 225. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 226. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 227. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 228. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 229. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 230. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 231. Global Universities Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 232. Global Universities Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 233. Global Universities Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 234. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 235. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 236. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 237. Global Established Biotech Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 238. Global Established Biotech Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 239. Global Established Biotech Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 240. Global Startup Biotech Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 241. Global Startup Biotech Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 242. Global Startup Biotech Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 243. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 244. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 245. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 246. Global Full Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 247. Global Full Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 248. Global Full Service Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 249. Global Niche Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 250. Global Niche Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 251. Global Niche Service Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 252. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 253. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 254. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 255. Global Generics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 256. Global Generics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 257. Global Generics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 258. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 259. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 260. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 261. Global Mid Size Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 262. Global Mid Size Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 263. Global Mid Size Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 264. Global Cloud Based Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 265. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 266. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
  • TABLE 267. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Artificial Intelligence, 2017-2032 (USD Million)
  • TABLE 268. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Bioinformatics, 2017-2032 (USD Million)
  • TABLE 269. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by High Performance Computing, 2017-2032 (USD Million)
  • TABLE 270. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 271. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Molecular Modeling, 2017-2032 (USD Million)
  • TABLE 272. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 273. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Infrastructure as a Service, 2017-2032 (USD Million)
  • TABLE 274. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Platform as a Service, 2017-2032 (USD Million)
  • TABLE 275. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Software as a Service, 2017-2032 (USD Million)
  • TABLE 276. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 277. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 278. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 279. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 280. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 281. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 282. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Deployment Model, 2017-2032 (USD Million)
  • TABLE 283. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Hybrid Cloud, 2017-2032 (USD Million)
  • TABLE 284. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Private Cloud, 2017-2032 (USD Million)
  • TABLE 285. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Public Cloud, 2017-2032 (USD Million)
  • TABLE 286. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 287. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by ADMET Prediction, 2017-2032 (USD Million)
  • TABLE 288. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Clinical Trial Design, 2017-2032 (USD Million)
  • TABLE 289. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Drug Repositioning, 2017-2032 (USD Million)
  • TABLE 290. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Lead Discovery, 2017-2032 (USD Million)
  • TABLE 291. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Target Identification, 2017-2032 (USD Million)
  • TABLE 292. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 293. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
  • TABLE 294. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 295. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 296. Asia-Pacific Cloud Based Drug Discovery Platform Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 297. North America Cloud Based Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 298. North America Cloud Based Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
  • TABLE 299. North America Cloud Based Drug Discovery Platform Market Size, by Artificial Intelligence, 2017-2032 (USD Million)
  • TABLE 300. North America Cloud Based Drug Discovery Platform Market Size, by Bioinformatics, 2017-2032 (USD Million)
  • TABLE 301. North America Cloud Based Drug Discovery Platform Market Size, by High Performance Computing, 2017-2032 (USD Million)
  • TABLE 302. North America Cloud Based Drug Discovery Platform Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 303. North America Cloud Based Drug Discovery Platform Market Size, by Molecular Modeling, 2017-2032 (USD Million)
  • TABLE 304. North America Cloud Based Drug Discovery Platform Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 305. North America Cloud Based Drug Discovery Platform Market Size, by Infrastructure as a Service, 2017-2032 (USD Million)
  • TABLE 306. North America Cloud Based Drug Discovery Platform Market Size, by Platform as a Service, 2017-2032 (USD Million)
  • TABLE 307. North America Cloud Based Drug Discovery Platform Market Size, by Software as a Service, 2017-2032 (USD Million)
  • TABLE 308. North America Cloud Based Drug Discovery Platform Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 309. North America Cloud Based Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 310. North America Cloud Based Drug Discovery Platform Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 311. North America Cloud Based Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 312. North America Cloud Based Drug Discovery Platform Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 313. North America Cloud Based Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 314. North America Cloud Based Drug Discovery Platform Market Size, by Deployment Model, 2017-2032 (USD Million)
  • TABLE 315. North America Cloud Based Drug Discovery Platform Market Size, by Hybrid Cloud, 2017-2032 (USD Million)
  • TABLE 316. North America Cloud Based Drug Discovery Platform Market Size, by Private Cloud, 2017-2032 (USD Million)
  • TABLE 317. North America Cloud Based Drug Discovery Platform Market Size, by Public Cloud, 2017-2032 (USD Million)
  • TABLE 318. North America Cloud Based Drug Discovery Platform Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 319. North America Cloud Based Drug Discovery Platform Market Size, by ADMET Prediction, 2017-2032 (USD Million)
  • TABLE 320. North America Cloud Based Drug Discovery Platform Market Size, by Clinical Trial Design, 2017-2032 (USD Million)
  • TABLE 321. North America Cloud Based Drug Discovery Platform Market Size, by Drug Repositioning, 2017-2032 (USD Million)
  • TABLE 322. North America Cloud Based Drug Discovery Platform Market Size, by Lead Discovery, 2017-2032 (USD Million)
  • TABLE 323. North America Cloud Based Drug Discovery Platform Market Size, by Target Identification, 2017-2032 (USD Million)
  • TABLE 324. North America Cloud Based Drug Discovery Platform Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 325. North America Cloud Based Drug Discovery Platform Market Size, by Academic Research Institutes, 2017-2032 (USD Million)
  • TABLE 326. North America Cloud Based Drug Discovery Platform Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 327. North America Cloud Based Drug Discovery Platform Market Size, by Contract Research Organizations, 2017-2032 (USD Million)
  • TABLE 328. North America Cloud Based Drug Discovery Platform Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 329. Latin America Cloud Based Drug Discovery Platform Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 330. Latin America Cloud Based Drug Discovery Platform Market Size, by Technology Type, 2017-2032 (USD Million)
  • TABLE 331. Latin America Cloud Based Drug Discovery Platform Market Size, by Artificial Intelligence, 2017-2032 (USD Million)
  • TABLE 332. Latin America Cloud Based Drug Discovery Platform Market Size, by Bioinformatics, 2017-2032 (USD Million)
  • TABLE 333. Latin America Cloud Based Drug Discovery Platform Market Size, by High Performance Computing, 2017-2032 (USD Million)
  • TABLE 334. Latin America Cloud Based Drug Discovery Platform Market Size, by Machine Learning, 2017-2032 (USD Million)
  • TABLE 335. Latin America Cloud Based Drug Discovery Platform Market Size, by Molecular Modeling, 2017-2032 (USD Million)
  • TABLE 336. Latin America Cloud Based Drug Discovery Platform Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 337. Latin America Cloud Based Drug Discovery Platform Market Size, by Infrastructure as a Service, 2017-2032 (USD Million)
  • TABLE 338. Latin America Cloud Based Drug Discovery Platform Market Size, by Platform as a Service, 2017-2032 (USD Million)
  • TABLE 339. Latin America Cloud Based Drug Discovery Platform Market Size, by Software as a Service, 2017-2032 (USD Million)
  • TABLE 340. Latin America Cloud Based Drug Discovery Platform Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 341. Latin America Cloud Based Drug Discovery Platform Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 342. Latin America Cloud Based Drug Discovery Platform Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 343. Latin America Cloud Based Drug Discovery Platform Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 344. Latin America Cloud Based Drug Discovery Platform Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 345. Latin America Cloud Based Drug Discovery Platform Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 346. Latin America Cloud Based Drug Discovery Platform Market Size, by Deployment Model, 2017-2032 (USD Million)
  • TABLE 347. Latin America Cloud Based Drug Discovery Platform Market Size, by Hybrid Cloud, 2017-2032 (USD Million)
  • TABLE 348. Latin America Cloud Based Drug Discovery Platform Market Size, by Private Cloud, 2017-2032 (USD Million)
  • TABLE 349. Latin America Cloud Based Drug Discovery Platform Market Size, by Public Cloud, 2017-2032 (USD Million)
  • TABLE 350. Latin America Cloud Based Drug Discovery Platform Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 351. Latin America Cloud Based Drug Discovery Platform Market Size, by ADMET Prediction, 2017-2032 (USD Million)
  • TABLE 352. Latin America Cloud Based Drug Discovery Platform Market Size, by Clinical Trial Design, 2017-2032 (USD Million)
  • TABLE 353. Latin America Cloud Based Drug Discovery Platform Market Size, by Drug Repositioning, 2017-2032 (USD Million)
  • TABLE 354. Latin America Cloud Based Drug Discovery Platform Market Size, by Lead Discovery, 2017-2032 (USD Million)
  • TABLE 355. Latin America Cloud Based Drug Discovery Platform Market Size, by Target Identification, 2017-2032 (USD Million)
  • TABLE 356. Latin America Cloud Based